Molina Healthcare Stock News

Medtronic (MDT) registers organic growth in the Cardiovascular, Neuroscience and Diabetes segments in Q3.

Within the last quarter, Molina Healthcare (NYSE:MOH) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 2 0 0 0 Last

Henry Schein (HSIC) stock rallies on strong fourth-quarter performance and bullish 2022 EPS guidance.

Shockwave Medical's (SWAV) fourth-quarter results reflect robust revenue growth and expansion in gross margin.

UnitedHealth Group's (UNH) unit UnitedHealthcare receives a contract from the District of Columbia aimed at improving health outcomes of District Dual Choice program enrollees in the district.

AMN Healthcare's (AMN) robust Q4 results demonstrate its segmental strength.

Syneos Health (SYNH) reports better-than-expected earnings for the fourth quarter and strong performances by the Clinical Solutions and Commercial Solutions arms.

Strength in Musculoskeletal Solutions and Enabling Technologies products drove Globus Medical's (GMED) Q4 revenues.

Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.

Baxter's (BAX) fourth-quarter results reflect robust performance across six of its business units.

West Pharmaceutical's (WST) fourth-quarter earnings reflect strength in the Proprietary Products segment and margin expansion.

Molina Healthcare Inc (MOH) shares closed today at 1.7% below its 52 week high of $328.11, giving the company a market cap of $18B. The stock is currently up 1.4% year-to-date, up 49.7% over the past 12 months, and up 555.6% over the past five years. This week, the Dow Jones Industrial Average fell 2.2%, and the S&P 500 fell 2.4%. Trading Activity Trading volume this week was 17.7% higher than the 20-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -181.6% The company's stock price performance over the past 12 months beats the peer average by 48.1% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -45.9% lower than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Style Box ETF report for XMHQ

Robust demand for research models, particularly in China, as well as higher revenues from research model services aid Charles River (CRL) in Q4.

According to Alcon (ALC), strong product flow results in above-market revenue growth, which drives core operating leverage and margin expansion.